Hm Payson & CO Vertex Pharmaceuticals Inc Transaction History

Hm Payson & CO

$5.81 Billion
Q3 2024

A detailed history of Hm Payson & CO transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Hm Payson & CO holds 7,075 shares of VRTX stock, worth $3.55 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

7,075

Previous 19,405 63.54%

Holding current value

$3.55 Million

Previous $9.1 Million 63.83%

% of portfolio

0.06%

Previous 0.17%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 28, 2024	SELL	$460.0 - $505.78 $5.67 Million - $6.24 Million	-12,330 Reduced 63.54%	7,075 $3.29 Million
Q2 2024 Aug 13, 2024	BUY	$392.81 - $485.53 $6.83 Million - $8.44 Million	17,389 Added 862.55%	19,405 $9.1 Million
Q1 2024 Jun 20, 2024	SELL	$407.69 - $446.08 $2,446 - $2,676	-6 Reduced 0.3%	2,016 $842,000
Q4 2023 Feb 13, 2024	BUY	$343.0 - $410.68 $677,425 - $811,093	1,975 Added 4202.13%	2,022 $822,000
Q3 2023 Nov 06, 2023	BUY	$338.18 - $362.46 $8,454 - $9,061	25 Added 113.64%	47 $16,000
Q1 2023 Apr 18, 2023	BUY	$283.23 - $323.1 $6,231 - $7,108	22 New	22 $6,000
Q3 2022 Oct 25, 2022	SELL	$273.83 - $305.53 $821 - $916	-3 Reduced 20.0%	12 $3,000
Q2 2022 Aug 15, 2022	BUY	$234.96 - $292.55 $704 - $877	3 Added 25.0%	15 $4,000
Q1 2022 May 12, 2022	BUY	$221.42 - $260.97 $2,657 - $3,131	12 New	12 $3,000
Q4 2021 Feb 15, 2022	SELL	$177.01 - $223.45 $6,195 - $7,820	-35 Closed	0 $0
Q3 2021 Nov 30, 2021	BUY	$181.39 - $202.99 $6,348 - $7,104	35 New	35 $6,000
Q2 2021 Aug 17, 2021	SELL	$187.49 - $221.1 $20,061 - $23,657	-107 Closed	0 $0
Q1 2021 Jun 15, 2021	SELL	$207.02 - $241.31 $7,659 - $8,928	-37 Reduced 25.69%	107 $23,000
Q3 2019 Nov 12, 2019	SELL	$166.23 - $187.09 $7,812 - $8,793	-47 Reduced 24.61%	144 $24,000
Q2 2019 Aug 15, 2019	BUY	$164.61 - $190.37 $31,440 - $36,360	191 New	191 $35,000

Others Institutions Holding VRTX

# of Institutions

1,716

Shares Held

225M

Call Options Held

1.19M

Put Options Held

1.56M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $129B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hm Payson & CO, based on Form 13F filings with the SEC.

News

Stay updated on Hm Payson & CO with notifications on news.

Account